Medicine · Français

Will NCT06356129 (Celgene) still show a study completion date of 26 June 2029 or earlier when checked on 26 July 2029?

deadline 2029-07-26 confidence low tier 1 evidence
48%Asturna estimate

Resolution criterion

Yes if, when NCT06356129 is read on clinicaltrials.gov on 26 July 2029, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 26 June 2029 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.

Verified starting state

As of 13 November 2026: NCT06356129 is registered as ACTIVE_NOT_RECRUITING, sponsored by Celgene, with 850 participants. Started 2024-06; announced primary completion 2027-08-09, announced study completion 2029-06-26. Record last updated 2026-07-06. The date under test is 2029-06-26. Source: clinicaltrials.gov/study/NCT06356129

What pushes it up

What pushes it down

What would move this number most

Whether unforeseen operational or regulatory issues will arise between now and mid‑2029

How this number is built

Deadline2029-07-26
Base rate40%
Best evidencetier 1 · 1 article(s) used
Independent runs35 · 38 · 48 · 55 · 68 (spread 33 pts)
Confidencelow
Evidence capnot triggered
Last revised2026-11-13 07:35
Modelopenai/gpt-oss-120b (Groq)

Sources consulted

ClinicalTrials.gov record NCT06356129 (sponsor: Celgene): overall status ACTIVE_NOT_RECRUITING; primary completion date 2027-08-09; study completion date 2029-06-26; status last verified by the sponsor 2026-07; record last updated 2026-07-06; enrollment 850 (estimated)tier 1 · ClinicalTrials.gov (U.S. National Library of Medicine) · 2026-07-06